FNY Investment Advisers, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 68 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
FNY Investment Advisers, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$0500.0%0.00%
Q1 2019$050
-9.1%
0.00%
Q4 2018$055
+1000.0%
0.00%
Q3 2018$050.0%0.00%
Q2 2018$050.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Perceptive Advisors 5,995,760$16,129,0001.12%
Palo Alto Investors LP 1,425,439$3,834,0000.29%
Granahan Investment Management 1,438,736$3,870,0000.14%
WealthTrust Axiom LLC 130,000$349,0000.13%
SHEPHERD KAPLAN KROCHUK, LLC 127,846$344,0000.09%
NIPPON LIFE INSURANCE CO 17,192$2,247,0000.06%
Joel Isaacson & Co., LLC 80,660$217,0000.05%
Cornerstone Capital, Inc. 47,200$127,0000.03%
OXFORD ASSET MANAGEMENT LLP 153,769$414,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,650$758,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders